- Home
- REPL vs HFWA Comparison
REPL vs HFWA Comparison
Compare REPL & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- HFWA
- Stock Information
- Founded
- REPL 2015
- HFWA 1927
- Country
- REPL United States
- HFWA United States
- Employees
- REPL N/A
- HFWA 761
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- HFWA Banks
- Sector
- REPL Health Care
- HFWA Finance
- Exchange
- REPL Nasdaq
- HFWA Nasdaq
- Market Cap
- REPL 757.8M
- HFWA 813.1M
- IPO Year
- REPL 2018
- HFWA N/A
- Fundamental
- Price
- REPL $9.40
- HFWA $25.61
- Analyst Decision
- REPL Strong Buy
- HFWA Hold
- Analyst Count
- REPL 7
- HFWA 3
- Target Price
- REPL $20.83
- HFWA $27.67
- AVG Volume (30 Days)
- REPL 1.1M
- HFWA 173.0K
- Earning Date
- REPL 08-07-2025
- HFWA 07-24-2025
- Dividend Yield
- REPL N/A
- HFWA 3.75%
- EPS Growth
- REPL N/A
- HFWA 11.50
- EPS
- REPL N/A
- HFWA 1.48
- Revenue
- REPL N/A
- HFWA $220,859,000.00
- Revenue This Year
- REPL N/A
- HFWA $23.49
- Revenue Next Year
- REPL N/A
- HFWA $7.68
- P/E Ratio
- REPL N/A
- HFWA $17.28
- Revenue Growth
- REPL N/A
- HFWA 0.16
- 52 Week Low
- REPL $6.44
- HFWA $17.04
- 52 Week High
- REPL $17.00
- HFWA $27.58
- Technical
- Relative Strength Index (RSI)
- REPL 50.70
- HFWA 71.49
- Support Level
- REPL $9.12
- HFWA $23.73
- Resistance Level
- REPL $9.73
- HFWA $23.95
- Average True Range (ATR)
- REPL 0.50
- HFWA 0.63
- MACD
- REPL -0.06
- HFWA 0.27
- Stochastic Oscillator
- REPL 41.17
- HFWA 97.11
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.